ROWYNA BOHLEN: Open Payments
NPI 1861558504 · STONY BROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 26 payments from 6 companies in 2025. Trend: 2023 $592 · 2024 $1,051 · 2025 $1,650
Food & beverage: $1,566Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $702 |
| Janssen Biotech, Inc. | 5 | $425 |
| Madrigal Pharmaceuticals | 3 | $405 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Lilly USA, LLC | 1 | $32 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, CREON, LINZESS, SKYRIZI, MAVYRET, XIFAXAN.
Industry payments across NY — which companies pay providers there.
